Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Morgan

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Neurochemistry International|June 3, 2006
Modulation of microglial activation state following passive immunization in amyloid depositing transgenic miceDave Morgan
Neurochemical Research|May 10, 2003
Learning and memory deficits in APP transgenic mouse models of amyloid depositionDave Morgan
Experimental Neurology|April 21, 2007
Amyloid, memory and neurogenesisDave Morgan
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Immunotherapy for Alzheimer's diseaseDave Morgan
Neuro-Degenerative Diseases|August 16, 2006
Mechanisms of A beta plaque clearance following passive A beta immunizationDave Morgan
CNS & Neurological Disorders Drug Targets|March 12, 2009
The role of microglia in antibody-mediated clearance of amyloid-beta from the brainDave Morgan
Expert Review of Vaccines|August 7, 2003
Antibody therapy for Alzheimer's diseaseDave Morgan
Behavioral Neuroscience|June 3, 2008
Amyloid, hyperactivity, and metabolism: theoretical comment on Vloeberghs et al. (2008)Dave Morgan, Marcia N Gordon
Journal of Alzheimer'S Disease : JAD|September 13, 2002
What evidence would prove the amyloid hypothesis? Towards rational drug treatments for Alzheimer's diseaseDave Morgan, R Kennedy Keller
Neurobiology of Aging|June 3, 2004
Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's diseaseDave Morgan, Bruce D Gitter
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Neurochemistry International|June 3, 2006
Modulation of microglial activation state following passive immunization in amyloid depositing transgenic miceDave Morgan
Neurochemical Research|May 10, 2003
Learning and memory deficits in APP transgenic mouse models of amyloid depositionDave Morgan
Experimental Neurology|April 21, 2007
Amyloid, memory and neurogenesisDave Morgan
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Immunotherapy for Alzheimer's diseaseDave Morgan
Neuro-Degenerative Diseases|August 16, 2006
Mechanisms of A beta plaque clearance following passive A beta immunizationDave Morgan
CNS & Neurological Disorders Drug Targets|March 12, 2009
The role of microglia in antibody-mediated clearance of amyloid-beta from the brainDave Morgan
Expert Review of Vaccines|August 7, 2003
Antibody therapy for Alzheimer's diseaseDave Morgan
Behavioral Neuroscience|June 3, 2008
Amyloid, hyperactivity, and metabolism: theoretical comment on Vloeberghs et al. (2008)Dave Morgan, Marcia N Gordon
Journal of Alzheimer'S Disease : JAD|September 13, 2002
What evidence would prove the amyloid hypothesis? Towards rational drug treatments for Alzheimer's diseaseDave Morgan, R Kennedy Keller
Neurobiology of Aging|June 3, 2004
Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's diseaseDave Morgan, Bruce D Gitter
Pageof 9